Sexuality and management of benign prostatic hyperplasia with alfuzosin 10mg once daily (Xatral OD 10mg), open, 24-week study.
Phase of Trial: Phase IV
Latest Information Update: 29 Sep 2009
At a glance
- Drugs Alfuzosin (Primary)
- Indications Lower urinary tract symptoms
- Focus Therapeutic Use
- Acronyms SAMBA
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 17 Dec 2008 Planned number of patients changed from 425 to 431 as reported by ClinicalTrials.gov.
- 08 Apr 2008 Status changed form in progress to completed, as reported in ClinicalTrials.gov.